Bernarda Zamora

Names

Affiliations

• Self-employed
  • English name: Self-employed
  • website
  • location: Spain

Research profile

author of:

• Female Labor Participation and the Allocation of Household Expenditure. Evidence on Spanish Data
  by Bernarda Zamora
• The Spanish Sharing Rule
  by Bernarda Zamora
• THE SPANISH SHARING RULE
  by Bernarda Zamora
• DOES FEMALE PARTICIPATION AFFECT THE SHARING RULE?
  by Bernarda Zamora
• “Rationality in the Joint Allocation of Private and Public Goods”.
  by Zamora, Bernarda
• Nature, nurture and market conditions: Ability and education in the policy evaluation approach
  by Bernarda Zamora Talaya & Eduard Gracia
• A NEW DISCUSSION OF THE HUMAN CAPITAL THEORY IN THE METHODOLOGY OF SCIENTIFIC RESEARCH PROGRAMMES
  by Bernarda Zamora
• Primary Education in India: Prospects of meeting the MDG Target
  by Sonia Bhalotra & Bernarda Zamora
• Primary Education in India: Prospects of Meeting the MDG Target
  by Sonia R. Bhalotra & Bernarda Zamora
• Primary Education in India Prospects of Meeting the MDG Target
  by Sonia Bhalotra & Bernarda Zamora
• Does female participation affect the sharing rule?
  by Bernarda Zamora
• NEW FORMS OF PROVIDER IN THE ENGLISH NATIONAL HEALTH SERVICE
  by Pauline Allen & Will Bartlett & Virginie Perotin & Bernarda Zamora & Simon Turner
• Does hospital ownership affect patient experience? An investigation into public–private sector differences in England
  by Pérotin, Virginie & Zamora, Bernarda & Reeves, Rachel & Bartlett, Will & Allen, Pauline
• Strategic Intelligence Monitor on Personal Health Systems, Phase 2. Impact Assessment Final Report.
  by Bernarda Zamora
• Strategic Intelligence Monitor on Personal Health Systems, Phase 2 -Interim Report on Impact Assessment State of the Art and Justifications
  by Bernarda Zamora
• Monitoring and Assessment Framework for the European Innovation Partnership on Active and Healthy Ageing (MAFEIP) – Inception Report
  by Ioannis Maghiros & Fabienne Abadie & Maria Lluch & Ramon Sabes-Figuera & Elena Villalba & Bernarda Zamora
• Monitoring and Assessment Framework for the European Innovation Partnership on Active and Healthy Ageing (MAFEIP) – Interim Report on the defined process indicators
  by Fabienne Abadie & Maria Lluch & Ramon Sabes-Figuera & Bernarda Zamora
• Monitoring and Assessment Framework for the European Innovation Partnership on Active and Healthy Ageing (MAFEIP) Second update of the process indicators
  by Fabienne Abadie & Christian Boehler & Maria Lluch & Ramon Sabes-Figuera & Bernarda Zamora
• Monitoring and Assessment Framework for the European Innovation Partnership on Active and Healthy Ageing (MAFEIP) First update of the process indicators
  by Fabienne Abadie & Maria Lluch & Ramon Sabes-Figuera & Bernarda Zamora
• The Debate on Indication-Based Pricing in the U.S. and Five Major European Countries
  by Towse, A. & Cole, A. & Zamora, B.
• Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England
  by Hernandez-Villafuerte, K. & Zamora, B. & Feng, Y. & Parkin, D. & Devlin, N. & Towse, A.
• The Distribution of the EQ-5D-5L Index in Patient Populations
  by Feng, Y. & Devlin, N. & Bateman, A. & Zamora, B. & Parkin, D.
• Assessing Trends in SMC Advice Decisions (October 2009- September 2015)
  by O'Neill, P. & Zamora, B.
• New Methods for Analysing the Distribution of EQ-5D Observations
  by Zamora, B. & Parkin, D. & Feng, Y. & Bateman, A. & Herdman, M. & Devlin, N.
• Routine Funding in the NHS in the UK of Medicines Authorised Between 2011 and 2016 via the European Centralised Procedure
  by Zamora, B. & Maignen, F. & Lorgelly, P.
• Comparing Access to Orphan Medicinal Products (OMPs) in the United Kingdom and other European countries
  by Zamora, B. & Maignen, F. & O'Neill, P. & Mestre-Ferrandiz, J. & Garau, M.
• Four Case Studies to Explore the Added Value of Oxford AHSN
  by Marsden, G. & Martin, A. & Zamora, B. & Exley, J. & Sussex, J. & Towse, A.
• Issues Surrounding the Estimation of the Opportunity Cost of Adopting a New Health Care Technology: Areas for Further Research
  by Hernandez-Villafuerte, K. & Zamora, B. & Towse, A.
• The Case of Risperidone: Assessing the Life-cycle Value of Second-Generation Antipsychotics in Sweden and the UK
  by Berdud, M. & Wallin-Bernhardsson, N. & Zamora, B. & Lindgren, P. & Towse, A.
• Indication-Based Pricing (IBP) Discussion Paper: Should drug prices differ by indication?
  by Cole, A. & Towse, A. & Zamora, B.
• Indication-Based Pricing (IBP) Consultation Report
  by Cole, A. & Towse, A. & Zamora, B.
• Unrelieved Pain in Palliative Care in England
  by Zamora, B. & Cookson, G. & Garau, M.
• Documento de debate sobre la fijación de precios en función de la indicación (IBP) ¿Deben variar los precios de los medicamentos según la indicación?
  by Cole, A. & Towse, A. & Zamora, B.
• Opportunities to Increase Efficiency in Healthcare
  by Errea, M. & Skedgel, C. & Zamora, B. & G., Hampson & R., Althin & Hofmarcher, T. & Lindgren, P. & Cookson, G.
• Examining the variation across acute trusts in patient delayed discharge
  by DeVolder, Russell & Serra-Sastre, Victoria & Zamora, Bernarda